Welcome to your source of quality news, articles, analysis and latest data.

Complete information on:

ACORDA THERAPEUTICS, INC. branch

Company data, financial data, shareholder information and contact data
Name:ACORDA THERAPEUTICS, INC. branch
Company number:2423574
Company status:Active
Incorporation date:29 September 1999 (over 21 years ago)
-
Company type:FOREIGN BUSINESS CORPORATION
Jurisdiction:New York (US)
Business number:unavailable
Registered address:28 LIBERTY STREET, NEW YORK, 10005, NEW YORK, United States
Agent name:unavailable
Identifiers:US Federal CAGE number: 305Q1, SEC CIK number: 1008848
Previous names:ACORDA THERAPEUTICS, INC.
Telephone numbers:["Number: +1 9143474300"]
Official register entries:[{"SEC Edgar entry":"register id: 1008848"}]
Websites:["http://www.acorda.com","http://www.acorda.com/"]
Company addresses:Company Address 420 SAW MILL RIVER ROAD, ARDSLEY NY 10502
Company Address 15 SKYLINE DR, HAWTHORNE, NY, 105322152
Head Office Address ACORDA THERAPEUTICS, INC., 420 SAW MILL RIVER ROAD, ARDSLEY, NEW YORK, 10502
Latest events:1999-09-29 - 2019-12-05 Addition of officer C T CORPORATION SYSTEM, registered agent
2019-10-01 - 2019-12-05 Removal of officer C T CORPORATION SYSTEM, dos process agent
2019-10-01 - 2019-12-05 Removal of officer RON COHEN MD, chief executive officer
Subsidiaries:0 ACORDA THERAPEUTICS LIMITED (United Kingdom, 3 Mar 2009- )
0 Biotie Therapies GmbH (Germany)
0 BIOTIE THERAPIES, INC. (Delaware (US), 22 Dec 2005- )
0 CIVITAS THERAPEUTICS, INC. (Delaware (US), 17 Jun 2009- )
0 Biotie Therapies AG (Switzerland)
Officers:ACORDA THERAPEUTICS, INC INC
C T CORPORATION SYSTEM registered agent
RON COHEN chief executive officer
Officers:
Data from other sources:
ACORDA THERAPEUTICS, INC., US133831168
From: US, NY, ARDSLEY
Contact: www.acorda.com, [email protected], +1 9143474300

Status:
FEDERATED INVESTORS INC via its funds Shareholder of Acorda Therapeutics, Inc.
FEDERATED INVESTORS INC via its funds Shareholder of Acorda Therapeutics, Inc.
MW GROUP LP via its funds Shareholder of Acorda Therapeutics, Inc.
MW GROUP LP via its funds Shareholder of Acorda Therapeutics, Inc.
MORGAN STANLEY via its funds Shareholder of Acorda Therapeutics, Inc.
MORGAN STANLEY via its funds Shareholder of Acorda Therapeutics, Inc.
SEI INVESTMENTS COMPANY via its funds Shareholder of Acorda Therapeutics, Inc.
SEI INVESTMENTS COMPANY via its funds Shareholder of Acorda Therapeutics, Inc.
OP OSUUSKUNTA via its funds Shareholder of Acorda Therapeutics, Inc.
TWO SIGMA ADVISERS, LP via its funds Shareholder of Acorda Therapeutics, Inc.
TWO SIGMA ADVISERS, LP via its funds Shareholder of Acorda Therapeutics, Inc.
PRUDENTIAL FINANCIAL INC. via its funds Shareholder of Acorda Therapeutics, Inc.
PRUDENTIAL FINANCIAL INC. via its funds Shareholder of Acorda Therapeutics, Inc.
MAN GROUP PLC via its funds Shareholder of Acorda Therapeutics, Inc.
MAN GROUP PLC via its funds Shareholder of Acorda Therapeutics, Inc.
CI FINANCIAL CORP. via its funds Shareholder of Acorda Therapeutics, Inc.
CI FINANCIAL CORP. via its funds Shareholder of Acorda Therapeutics, Inc.
CONNOR, CLARK & LUNN FINANCIAL GROUP LTD. via its funds Shareholder of Acorda Therapeutics, Inc.
CONNOR, CLARK & LUNN FINANCIAL GROUP LTD. via its funds Shareholder of Acorda Therapeutics, Inc.
TWO SIGMA INVESTMENTS via its funds Shareholder of Acorda Therapeutics, Inc.
TWO SIGMA INVESTMENTS via its funds Shareholder of Acorda Therapeutics, Inc.
CREDIT SUISSE GROUP AG via its funds Shareholder of Acorda Therapeutics, Inc.
CREDIT SUISSE GROUP AG via its funds Shareholder of Acorda Therapeutics, Inc.
ALGER ASSOCIATES, INC. (UNITED STATES) via its funds Shareholder of Acorda Therapeutics, Inc.
ALGER ASSOCIATES, INC. (UNITED STATES) via its funds Shareholder of Acorda Therapeutics, Inc.
AXA EQUITABLE HOLDINGS INC. via its funds Shareholder of Acorda Therapeutics, Inc.
AXA EQUITABLE HOLDINGS INC. via its funds Shareholder of Acorda Therapeutics, Inc.
WELLINGTON MANAGEMENT GROUP LLP via its funds Shareholder of Acorda Therapeutics, Inc.
WELLINGTON MANAGEMENT GROUP LLP via its funds Shareholder of Acorda Therapeutics, Inc.
Mr Richard P Batycky Previously worked for (Chief Technology Officer and Site Head) Acorda Therapeutics, Inc.
Mr David W Lawrence Previously worked for (Chief - Business Operations) Acorda Therapeutics, Inc.
Mr Michael William Rogers Previously worked for (Chief Financial Officer) Acorda Therapeutics, Inc.
Mr Andrew Asa Hindman Previously worked for (Chief Business Officer) Acorda Therapeutics, Inc.
Mr Ian F. Smith Previously worked for (Independent Director) Acorda Therapeutics, Inc.
Dr. Andrew R. Blight Previously worked for (Chief Scientific Officer) Acorda Therapeutics, Inc.
Other companies:
All information found on this page is extracted from public sources and should not be used in any official way.